Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors.
about
Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxaneTargeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcomaVEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedsideRemodeling Components of the Tumor Microenvironment to Enhance Cancer TherapyRho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunitiesExploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunitiesThe impact of the myeloid response to radiation therapyMicrovascular repair: post-angiogenesis vascular dynamicsLocoregional drug delivery using image-guided intra-arterial drug eluting bead therapyResistance and escape from antiangiogenesis therapy: clinical implications and future strategiesThe clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunitiesTargeting the tumor vasculature to enhance T cell activitySelective alpha-particle mediated depletion of tumor vasculature with vascular normalizationReal-time visualization and quantitation of vascular permeability in vivo: implications for drug deliveryFibroblast Growth Factor 9 Imparts Hierarchy and Vasoreactivity to the Microcirculation of Renal Tumors and Suppresses MetastasesMural cell associated VEGF is required for organotypic vessel formationThe ever-expanding role of HIF in tumour and stromal biology(3)D [corrected] quantification of tumor vasculature in lymphoma xenografts in NOD/SCID mice allows to detect differences among vascular-targeted therapiesTumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab TherapyIntravital Microscopy Imaging Approaches for Image-Guided Drug Delivery SystemsEffects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948)Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed?Silk fibroin-derived nanoparticles for biomedical applications.Enhancing Tumor Penetration of Nanomedicines.Targeting the vascular endothelial growth factor pathway in the treatment of human malignancy.Endothelial Thermotolerance Impairs Nanoparticle Transport in Tumors.Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors.Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.Xenotropic MLV envelope proteins induce tumor cells to secrete factors that promote the formation of immature blood vessels.Molecular imaging agents: impact on diagnosis and therapeutics in oncologyVascular normalization as a therapeutic strategy for malignant and nonmalignant disease.Normalization of the vasculature for treatment of cancer and other diseases.Pulsed ultrasound enhances nanoparticle penetration into breast cancer spheroids.Radiation-induced tumor neoantigens: imaging and therapeutic implications.Determination of breast cancer response to bevacizumab therapy using contrast-enhanced ultrasound and artificial neural networksAZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging.Implanted microvessels progress through distinct neovascularization phenotypesTumors as organs: complex tissues that interface with the entire organismCauses, consequences, and remedies for growth-induced solid stress in murine and human tumors.
P2860
Q24314623-5C8424B1-96C0-42E0-9B0E-6758D4574942Q26747666-ED3D8FF8-0849-4E1F-B5A6-7D59DBC6C3EFQ26770678-F66C33CF-E956-4A1E-B65D-86D32319AACCQ26777144-8FC694C2-6225-4879-A596-F5415BAD23E4Q26778344-6F8BE2F4-B05B-42A9-A1A8-21F18B9DAF4DQ26828930-31F6FEDF-DA51-4949-BB3C-6BDB22040FB0Q26851643-5968F569-3C8F-48D0-B74C-607068C67001Q27004093-AE642684-08E9-427B-89CE-F504D032C499Q27015918-0B77AE02-BB1B-404E-876B-BCF80612C68FQ27016629-A5369AF4-2380-44DC-B990-F97FD186E7A1Q27025579-D076474F-5548-4091-BBEF-F0549B695C18Q27026329-238AF254-99C0-4576-93F8-22ECB5749AA5Q27303072-E32FCF51-1A3D-433F-A007-A71844761E3AQ27306235-82B0C8EB-FAEB-4C85-9278-FA43A6E33B43Q27312628-AA36F60F-65A7-4C5C-9737-687CBA4E6D15Q27348757-0EF8A3D3-C5A8-4449-83DE-855145422750Q28079015-90EEB2D3-C9DC-401B-BB70-E950E316D6FCQ28488869-8E32B1DA-DDA7-4DD9-8C6C-6AEBFCB68E2AQ28550733-1AA56198-3E2C-4DF2-ADB4-44B3DDA49FB1Q28553638-28BA200D-2116-4C2A-8715-E71FC7301CD6Q28732214-769B48B7-E010-41C2-A122-CD266B7A24F8Q29308099-93F54B47-299C-4E97-9CD7-A7310FAAE04FQ30156091-73143C32-1B1A-4E0D-995D-E15E75EBC701Q30356887-7DFEB353-A086-43A0-A828-0F1D6D0CD2C1Q30358961-B93D1192-FD4A-4BB9-8E04-2D44C74B5B91Q30376502-38F77124-8FE4-4772-87A9-9C493A09C3D7Q30388655-3A0736D9-42C2-42FF-A299-5B0265749A19Q30399006-CCE15068-4D67-43DA-852F-A961E723E209Q30418789-46407E4D-B8E7-41CE-895F-419162D5438BQ30433423-056234AE-C804-42F9-B6CC-875B8F063918Q30469815-9FEDD26C-D4DD-43A9-A4A0-8C9FEC9CA4FEQ30471456-F1F49761-202F-46B7-B4E7-CB89FEE3747AQ30472417-47AE8B93-9A44-4F79-936B-CA7DA36EDD56Q30473856-A226ACDC-8633-4074-899B-822B44F3CE08Q30475052-FBAF8D36-EAB1-4269-A5BB-0D952315F65AQ30490422-F2E65389-931D-43FF-B20B-11C2A2FF1635Q30490862-DC999449-461B-4A96-9D9A-B5FB0E556BA6Q30492935-578EFD59-9126-4CE3-8E50-799DB02BDE83Q30495528-7D1731F3-3F05-48A2-BE7F-FF82AEB7A43AQ30525290-E2E05912-A7C6-43F0-8ECF-6301DB060C65
P2860
Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Vascular normalization by vasc ...... es drug penetration in tumors.
@en
type
label
Vascular normalization by vasc ...... es drug penetration in tumors.
@en
prefLabel
Vascular normalization by vasc ...... es drug penetration in tumors.
@en
P2093
P1433
P1476
Vascular normalization by vasc ...... es drug penetration in tumors.
@en
P2093
Daniel J Hicklin
Frank Winkler
Rakesh K Jain
Ricky T Tong
Sergey V Kozin
Yves Boucher
P304
P356
10.1158/0008-5472.CAN-04-0074
P407
P577
2004-06-01T00:00:00Z